AOP2014, a Novel Peg-Proline-Interferon Alpha-2b with Improved Pharmacokinetic Properties, Is Safe and Well Tolerated and Shows Promising Efficacy in Patients with Polycythemia Vera (PV)

Gisslinger, H, Kralovics, R, Gisslinger, B, Lechner, D, Buxhofer-Ausch, V, Strecker, K, Gastl, G, Willenbacher, E, Greil, R, Egle, A, Melchardt, T, Burgstaller, S, Schloegl, E, Tarmann, FJ, Zoerer, M, Klade, C, Zahriychuk, O, Thaler, J BLOOD. 2012, 120(21):

Treatment of Aggressive B-Cell Lymphoma in the Elderly: The Influence of SNPs Affecting Pharmacodynamics Is Different Compared to Younger Patient

Melchardt, T, Weiss, L, Hufnagl, C, Neureiter, D, Kemmerling, R, Morre, P, Boekstegers, A, Hopfinger, G, Greil, R, Egle, A BLOOD. 2012, 120(21):

Complications of 5-azacytidine: Three cases of severe colitis in a single center cohort

Melchardt, T, Weiss, L, Pleyer, L, Steinkirchner, S, Greil, R, Egle, A ONKOLOGIE. 2012, 35: 149-149.

First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.

Bergh J, Bondarenko IM, Lichinitser MR, Liljegren A, Greil R, Voytko NL, Makhson AN, Cortes J, Lortholary A, Bischoff J, Chan A, Delaloge S, Huang X, Kern KA, Giorgetti C. J Clin Oncol. 2012 Mar 20,30(9):921-9. doi: 10.1200/JCO.2011.35.7376. Epub 2012 Feb 13.

Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.

Dubsky PC, Jakesz R, Mlineritsch B, Pöstlberger S, Samonigg H, Kwasny W, Tausch C, Stöger H, Haider K, Fitzal F, Singer CF, Stierer M, Sevelda P, Luschin-Ebengreuth G, Taucher S, Rudas M, Bartsch R, Steger GG, Greil R, Filipcic L, Gnant M. J Clin Oncol. 2012 Mar 1,30(7):722-8. doi: 10.1200/JCO.2011.36.8993. Epub 2012 Jan 23.

Influence of the American ODAC statement on Austrian bevacizumab prescribing practice for metastatic breast cancer.

Preusser M, Fülöp G, Berghoff AS, Heinzl H, Steger GG, Greil R, Zielinski CC, Bartsch R. Oncologist. 2012,17(7):e13-7. doi: 10.1634/theoncologist.2012-0115. Epub 2012 Jun 27.

[Safety of immunosuppressants].

Psenak O, Studnicka-Benke A, Greil R. Z Rheumatol. 2012 Jul,71(5):420-9. doi: 10.1007/s00393-012-0990-z.

Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study.

Thaler J, Karthaus M, Mineur L, Greil R, Letocha H, Hofheinz R, Fernebro E, Gamelin E, Baños A, Köhne CH. BMC Cancer. 2012 Sep 29,12:438. doi: 10.1186/1471-2407-12-438.

Novel treatment avenues for peripheral T-cell lymphomas.

Hopfinger G, Griessl R, Sifft E, Taylor N, Kenner L, Greil R, Merkel O. Expert Opin Drug Discov. 2012 Dec,7(12):1149-63. doi: 10.1517/17460441.2012.727392. Epub 2012 Sep 24.

What paths are open for tackling increasing azole resistance in Aspergillus in the clinic?

Auberger J, Greil R, Lass-Flörl C. Expert Rev Anti Infect Ther. 2012 Nov,10(11):1229-31. doi: 10.1586/eri.12.126.